Jason Moore, PhD, Director of the Institute for Biomedical Informatics, provides a synopsis of bioinformatics, the collective pieces of information that define an individual’s physiology and that can be harnessed to provide a personalized diagnosis for disease, as well as the most appropriate treatment.
Related Links
- Clinical Briefing: Personalized Diagnostics for Hematologic and Solid Tumor Cancers
- Case Study: After genomic profiling, a 43yearold man with nonsmall cell lung cancer is found to have an EML4ALK mutation amenable to treatment with crizotinib, an oral, small molecule tyrosine kinase inhibitor that targets ALK.
- Dr. Moore’s Profile
Published
July 2, 2015
Created by
BROADCASTMED